What is EyeQue?
Founded in 2015, EyeQue operates at the intersection of consumer self-care and professional clinical oversight. The company provides a sophisticated suite of at-home diagnostic tools that allow patients to update prescriptions and monitor ocular health between traditional office visits. By facilitating a seamless data bridge between patients and eye care professionals, EyeQue enables practitioners to adopt telemedicine workflows, thereby enhancing patient engagement and practice efficiency. This model addresses the growing market demand for remote health monitoring and personalized vision care, establishing the company as a critical infrastructure provider in the modern ophthalmology landscape.
How much funding has EyeQue raised?
EyeQue has raised a total of $72.7M across 4 funding rounds:
Series A
$3.5M
Series B
$11.2M
Debt
$1M
Series C
$57M
Series A (2016): $3.5M with participation from Align Capital
Series B (2018): $11.2M, investors not publicly disclosed
Debt (2020): $1M supported by PPP
Series C (2021): $57M, investors not publicly disclosed
Key Investors in EyeQue
Align Capital
A venture capital firm specializing in early-stage investments and strategic growth support for technology-driven enterprises.
Undisclosed Investor
Undisclosed investor participating in the funding round.
Undisclosed Investor
Undisclosed investor participating in the funding round.
What's next for EyeQue?
With the recent capital injection, EyeQue is expected to prioritize the expansion of its clinical integration platform and the scaling of its consumer-facing diagnostic hardware. The strategic focus will likely shift toward deepening partnerships with eye care providers to standardize remote monitoring protocols. As the company matures, it will likely leverage this financial backing to enhance its data analytics capabilities, providing doctors with more granular insights into patient treatment effectiveness. This phase of growth is critical for solidifying EyeQue's market position as a leader in the digital transformation of eye care, ensuring that its technology remains a staple in both clinical and home-based health management ecosystems.
See full EyeQue company page
